Structural Biology and Molecular Modeling Market

Market Snapshot

Market Synopsis:

Global Structural Biology and Molecular Modeling market is valued at USD 6.1 Billion in 2021 and is projected to attain a value of USD 18.1 Billion by 2028 at a CAGR of 17.1% during the forecast period, 2022–2028. The rise in the prevalence of chronic diseases with acquired drug resistance is driving the market, demonstrating the need for novel and enhanced therapies. As a result, there is a great deal of clinical urgency to include Structural Biology and Molecular Modeling tools into the development of novel medications.

COVID-19 pandemic has wreaked havoc on the world's population's health and wreaked havoc on most countries' economies. Due to the fact that social separation is the only available method capable of limiting exposure, the COVID-19 pandemic presents enormous prospects for Structural Biology and Molecular Modeling solutions. Structural Biology and Molecular Modeling, in accordance with this, is an appealing, effective, and cost-efficient solution. Furthermore, this technology is crucial in ensuring the safety of healthcare providers.

Technological Advancements

The emergence of technical breakthroughs has resulted in the development of proven mathematical models that allow for the correct determination of structures and the prediction of cellular functions and interactions, assisting in the identification of novel leads with a higher probability. Furthermore, advances in silico drug design tools, combined with a multidisciplinary approach involving computational biology, molecular biology, and biophysics, are yielding novel methods that aid structural biologists in comprehending diverse protein sequences and accurately predicting protein structures. These unique methods are thought to improve biomedical research and help solve problems, consequently improving drug discovery and increasing demand for modelling tools.

High Cost in R&D Activities and Dearth of Skilled Professionals

Data from genomics can be used for a variety of purposes, including pharmacogenomics, diagnostics, and toxicogenomics. The analysis of massive amounts of data generated in genomics research, on the other hand, is a serious difficulty. In some circumstances, technical improvements have made it possible for the instruments in use to give an analysis; nonetheless, the reader's interpretation is still up to them. It is vital to recruit skilled professionals to evaluate and interpret the outcomes of genome sequencing data due to the intricacies involved and the requirement for in-depth understanding in the field of genomics. However, due to a scarcity of qualified individuals, a number of end users are having difficulty processing genomic data.

Market Segmentation:

The Global Structural Biology and Molecular Modeling Market can be segmented by Tools into SaaS and Standalone Modeling, Visualization and Analysis. Based on Application into Drug Development, Drug Discovery, and Other Applications. Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America And Middle East & Africa.

North America to Continue Dominating the Structural Biology and Molecular Modeling Market

In 2021, North America held the greatest proportion of the Structural Biology and Molecular Modeling market. Factors such as the increased prevalence of chronic illnesses, the need to cut healthcare spending, and the growing general and senior population can all be related to this region's considerable proportion of the worldwide Structural Biology and Molecular Modeling industry. In addition, the growing need to reduce COVID-19 cases, federal mandates to expand healthcare facilities, and a growing focus on improving the quality of care delivered to COVID-19 patients are some of the key factors driving the Structural Biology and Molecular Modeling market's growth in the United States in the aftermath of COVID-19.

Key Players:

Dassault Systèmes (France) , Agile Molecule , Acellera Ltd. (UK), ThermoFisher Scientific (US), Agilent Technologies Inc. (US) are the major companies operating in Structural Biology and Molecular Modeling Techniques Market.

The Structural Biology and Molecular Modeling market is segmented as follows:

Structural Biology and Molecular Modeling Market is tabulated as follows: